<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="virus infection [8], remdesivir is a prodrug of the parent" exact="adenosine" post="analog, GS-441524 (Fig. 1b), both of which are metabolized"/>
 <result pre="host metabolizes remdesivir into active NTP, the metabolite competes with" exact="adenosine" post="triphosphate (ATP; the natural nucleotide normally used in this"/>
 <result pre="inhibiting SARS-CoV-2. EC50 values ranged widely from 109.5 μM for" exact="ribavirin" post="to 1.13 μM for choloquine and 0.77 μM for"/>
 <result pre="a different amino acid at a specific site (phenylalanine to" exact="leucine" post="at residue 483), a dissimilarity that has been previously"/>
 <result pre="that is being evaluated in multiple trials against COVID-19 is" exact="chloroquine" post="(or hydroxychloroquine), which is already approved as an antimalarial"/>
 <result pre="naturally occurring feline infectious peritonitisJ. Feline Med. Surg.214201927128130755068 17WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
</results>
